← Eichor
Study identifier: NCT07443085 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery

Condition: Delirium - Postoperative  ·  Sponsor: Benha University

PhasePhase 2
Planned participants75
Who can joinAll sexes, 55 Years to 70 Years
Healthy volunteersNo

About this study

This study evaluates the dose-response relationship of Dexmedetomidine (DEX) in reducing the incidence and severity of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) in elderly patients. The study compares different doses of DEX against a fentanyl control group in patients undergoing major lower limb orthopedic surgery under general anesthesia to determine the optimal dosage for cognitive protection.

This description comes directly from the study's public registry record.

Talk to the study team

Islam Shaboub, MD  ·  01062702236  ·  basmasalem758@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Benha universityBanhā, Al Qalyobia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07443085